FDA Import Refusal SCS-6781666-2/21/2 — AADPRI OPHTHALMIC COMPANY
The FDA refused shipment SCS-6781666-2/21/2 from AADPRI OPHTHALMIC COMPANY (India) on Oct 14, 2021. The refused product falls under Drugs and Biologics — MITOMYCIN (ANTITUMOR). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- Oct 14, 2021
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 56HIY45 MITOMYCIN (ANTITUMOR)
- Charges
- 75